Skip to content

Novo Nordisk A/S Sustainability Reports

Novo Nordisk A/S is a global healthcare company specializing in diabetes care, obesity management, and other serious chronic diseases. The company discovers, develops, manufactures, and markets pharmaceutical products worldwide.

Sector: Manufacturing

Country: Denmark

Exchange: Nasdaq Copenhagen

LEI: 549300DAQ1CVT6CXN342

FIGI: BBG001S6RN12

26 reports from 2006 to 2025